Valuation : ALTEOGEN Inc.

Market Cap 19,462B 14.51B 12.47B 11.73B 10.71B 19.98B 1,375B 20.09B 139B 53.78B 703B 54.47B 53.28B 2,237B P/E 2026 *
64.9x
P/E 2027 * 47.9x
Enterprise Value 18.98B 14.15M 12.17M 11.44M 10.44M 19.49M 1.34B 19.59M 136M 52.46M 686M 53.13M 51.97M 2.18B EV / Sales 2026 *
40.4x
EV / Sales 2027 * 28.4x
Free-Float
74.26%
Yield 2026 *
0.17%
Yield 2027 * 0.2%
1 day-3.15%
1 week-7.97%
Current month-9.92%
1 month-9.18%
3 months+24.39%
6 months-3.46%
Current year-19.89%
1 week 277,000
Extreme 277000
313,500
1 month 277,000
Extreme 277000
356,000
Current year 194,615.38
Extreme 194615.384615
406,923.08
1 year 194,615.38
Extreme 194615.384615
437,692.31
3 years 33,846.15
Extreme 33846.153846
437,692.31
5 years 21,442.31
Extreme 21442.307691
437,692.31
10 years 2,804.49
Extreme 2804.487177
437,692.31
Manager TitleAgeSince
Chief Executive Officer 61 26/12/2025
Director of Finance/CFO 61 28/03/2023
Corporate Officer/Principal - -
Director TitleAgeSince
Chairman 71 13/05/2008
Director/Board Member 70 29/03/2021
Director/Board Member 61 28/03/2023
Date Insider Type Main position Quantity % Market Cap. Importance
21/05/25 Exercice

Chief Executive Officer

7,200 0.0135%
27/03/24 Sell 1,600,000 3.0182%
05/01/24 Sell 6,000 0.0115%
Change 5-day change 1-year change 3-year change Capi.($)
-3.15%-7.97%-24.67%+719.34% 14.38B
-1.03%-5.63%+44.48%-3.53% 80.91B
-0.78%-1.52%-18.45%-36.25% 60.46B
-1.33%-7.55%+469.80%+31.79% 56.02B
-1.77%-5.26%-9.16%+29.36% 49.63B
-0.77%-6.94%-1.87%+148.97% 45.88B
-0.24%-4.79%+47.64%-18.12% 31.4B
+0.16%-3.15%+45.76%+93.71% 25.22B
-2.00%-3.54%-2.68%+156.40% 22.25B
-2.34%-1.36%+62.26%+102.34% 16.59B
Average -1.34%-2.11%+61.31%+122.40% 40.27B
Weighted average by Cap. -1.17%-1.64%+78.30%+61.85%

Financials

2026 *2027 *
Net sales 470B 350M 301M 283M 259M 483M 33.21B 485M 3.36B 1.3B 16.97B 1.32B 1.29B 54.02B 660B 492M 423M 398M 363M 678M 46.65B 681M 4.72B 1.82B 23.85B 1.85B 1.81B 75.88B
Net income 298B 222M 191M 180M 164M 306M 21.09B 308M 2.13B 825M 10.78B 835M 817M 34.3B 379B 282M 243M 229M 209M 389M 26.78B 391M 2.71B 1.05B 13.69B 1.06B 1.04B 43.56B
Net Debt -478B -356M -306M -288M -263M -491M -33.77B -493M -3.41B -1.32B -17.26B -1.34B -1.31B -54.93B -730B -544M -468M -440M -401M -749M -51.55B -753M -5.21B -2.02B -26.35B -2.04B -2B -83.85B
Logo ALTEOGEN Inc.
Alteogen Inc is a Korea-based company primarily engaged in the research, development, and sales of biopharmaceuticals. The Company develops, produces, and sells biopharmaceuticals, including biobetters and novel biopharmaceuticals, based primarily on hyaluronidase protein engineering technology, sustained-release biopharmaceutical technology, and next-generation antibody-drug conjugate technology. In addition, the Company is engaged in research, development, and commercialization of biosimilars.
Employees
181
Date Price Change Volume
08/09/26 ₩277,000.00 -3.15% 657,576
07/09/26 ₩286,000.00 -0.87% 481,793
04/09/26 ₩288,500.00 +1.94% 613,855
03/09/26 ₩283,000.00 -5.19% 1,248,714
02/09/26 ₩298,500.00 -0.83% 2,219,578
Trader
Investor
Global
Quality
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
6
Last Close Price
277,000.00KRW
Average target price
382,051.28KRW
Spread / Average Target
+37.92%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. A196170 Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!